Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
127
days
Barriers and facilitators to the implementation of pharmacogenomic testing for antidepressants use in primary care: a systematic review using the consolidated framework for implementation research
AuthorsMuireann Counihan; Deirdre Cushen; Sookyung Kwak; Amy Allen; Donnchadh Fitzsimons Mac Giolla Chuda; Weronika Romanska; Ibrahim Nakchbandi; Rose Reynolds; Chad Bousman; Mark Ledwidge; Joseph Gallagher; Cristín Ryan
Affiliations1. School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland; 2. Department of Medical Genetics, University of Calgary, Calgary, Canada; 3. School of Medicine, University College Dublin, Belfield, Ireland
235
days
Amplicon-based long-read sequencing for accurate CYP2D6 gene deletion and duplication detection using CYP2D7 as a reference gene
AuthorsKiflu Gebremicael Tesfamicael; Michael Musker; David L. Adelson; Martin David Lewis
Affiliations1. Lifelong Health, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia; 2. School of Biological Sciences, Adelaide University, Adelaide, Australia; 3. South Australian Research and Development Institute (SARDI), Department of Primary Industries and Regions, Adelaide, Australia; 4. School of Nursing and Midwifery, College of Health, Adelaide University, Adelaide, Australia; 5. South Australian Museum, Adelaide, Australia
372
days
Association between CYP2D6 genotype and treatment effectiveness and safety in 99 hospitalized patients with major depressive disorder a retrospective cohort study CYP2D6 genotype and antidepressant response
AuthorsAleksandra Petković Ćurčin; Aleksandra Jeremić; Danilo Joković; Gordana Šupić; Katarina Simić; Filip Milosavljević; Zvezdana Stojanović; Marin M. Jukić
Affiliations1. Faculty of Medicine, Military Medical Academy, University of Defense, Belgrade, Serbia; 2. Institute for Medical Research, Military Medical Academy, Belgrade, Serbia; 3. Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia; 4. Clinic for Psychiatry, Military Medical Academy, Belgrade, Serbia; 5. Department of Psychiatry, Berkshire Medical Center, Pittsfield, United States of America; 6. Department of Psychiatry and Psychotherapy, School of Medicine, Technische Universität München, München, Germany; 7. Department of Physiology and Pharmacology, Karolinska Institute, Solna, Sweden
497
days
Large-scale analysis demonstrates the influence of CYP2C19 genotype on specific SSRI side effects
AuthorsChris Eijsbouts; Yunxuan Jiang; James R. Ashenhurst; Julie M. Granka; Steven Pitts; Adam Auton; Noura S. Abul-Husn; Alison Chubb; R. Ryanne Wu
Affiliations1. 23andMe Research Institute, Palo Alto, USA
77
days
Effects of CYP3A4, CYP3A5 , and ABCB1 genetic variants on tacrolimus metabolism during the early period after kidney transplantation
AuthorsNahathai Dukaew; Kajohnsak Noppakun; Mingkwan Na Takuathung; Nattharinee Kongta; Ratchanon Inpan; Naruemon Suyayai; Nut Koonrungsesomboon
Affiliations1. Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 2. Clinical Research Center for Food and Herbal Product Trials and Development (CR-FAH), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 3. School of Health Science, Mae Fah Luang University, Chiang Rai, Thailand; 4. Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 5. Pharmacoepidemiology and Statistics Research Center, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; 6. Office of Research Administration, Chiang Mai University, Chiang Mai, Thailand; 7. Transplant and Dialysis Unit, Medical Nursing Division, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand; 8. Center of Multidisciplinary Technology for Advanced Medicine (CMUTEAM), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
123
days
Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study
AuthorsAmy Mathieson; Lisa Brunton; Stephanie Gillibrand; Ramona Moldovan; John H. McDermott
Affiliations1. Centre for Primary Care and Health Services Research, University of Manchester, Greater Manchester, UK; 2. Division of Evolution & Genomic Sciences, University of Manchester, Greater Manchester, UK; 3. Manchester Centre for Genomic Medicine, Saint Mary’s Hospital, Manchester, Greater Manchester, UK; 4. Department of Psychology, Babeș-Bolyai University, Cluj-Napoca, Romania
119
days
Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants
AuthorsJM Rodríguez-Piñas; A. Romero-Lorca; A. Novillo; M. Gaibar; M. Rubio; B. Antón-Pascual; S. Hernando; I. Alemany; FI Camacho; M. Cavanagh; M. Boiza; D. Marrupe; AM Martín; R. Khedaoui; A. Fernández-Santander
Affiliations1. Department of Medicine, Faculty of Medicine, Health and Sports. Universidad Europea de Madrid, Madrid, Spain; 2. Human Genetic Variability Group, Hospital La Paz Institute for Health Research–IdiPAZ (La Paz University Hospital–Universidad Autónoma de Madrid–Getafe University Hospital–Universidad Europea de Madrid), Madrid, Spain; 3. Department of Cell Biology, Faculty of Medicine, Complutense University, Madrid, Spain; 4. Facultad HM de Ciencias de la Salud, Universidad Camilo José Cela, Instituto de Investigación Sanitaria HMHospitales, Madrid, Spain; 5. Department of Medical Oncology, Hospital Universitario Ramon y Cajal, Madrid, Spain; 6. Department of Medical Oncology, Hospital Universitario Fundación Alcorcón, Madrid, Spain; 7. Department of Pathological Anatomy, Hospital Universitario Fundación Alcorcón, Madrid, Spain; 8. Department of Pathological Anatomy, Hospital Universitario de Getafe, Madrid, Spain; 9. Department of Medical Oncology, Hospital Universitario de Getafe, Madrid, Spain; 10. Department of Pathological Anatomy, Hospital Universitario de Móstoles, Madrid, Spain; 11. Department of Medical Oncology, Hospital Universitario de Móstoles, Madrid, Spain; 12. Department of Medical Oncology, Hospital Universitario de Fuenlabrada, Madrid, Spain; 13. Department of Pathological Anatomy, Hospital Universitario de Fuenlabrada, Madrid, Spain
296
days
Beyond the ‘Pregnancy Black Box’: a global roadmap for artificial intelligence-driven pharmacogenomics in maternal-neonatal health
AuthorsMohamed A. Ismail
Affiliations1. Hamad Medical Corporation, Doha, Qatar
212
days
The association of ABCB1, CYP2C19 and CYP2C9 combined activity with clopidogrel resistance in patients with recurrent ischemic stroke
AuthorsBirgit Deiman; Mike Hermans; Maarten de Rijk; Anne Bras; Volkher Scharnhorst
Affiliations1. Catharina Hospital Eindhoven, Department of Clinical Chemistry, Eindhoven, the Netherlands; 2. Catharina Hospital Eindhoven, Department of Neurology, Eindhoven, the Netherlands
81
days
Cost-effectiveness of genome-guided statin treatment for hypercholesterolemia
AuthorsMargarita-Ioanna Koufaki; Korina Tzerefou; Achilleas Tyrovolas; Vladimir Gasic; Vassilios Fragoulakis; Christina Mitropoulou
Affiliations1. University of Patras, School of Health Sciences, Department of Pharmacy, Laboratory of Pharmacogenomics and Individualized Therapy, Patras, Greece; 2. The Golden Helix Foundation, London, UK; 3. Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Republic of Serbia; 4. United Arab Emirates University, College of Medicine and Health Sciences, Department of Genetics and Genomics, Al-Ain, UAE
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days